2 min read
Scientists use AI to design new class of GPCR drugs called GEMs
Researchers designed new proteins called GEMs that target GPCRs, like the dopamine D1 receptor, as diverse allosteric modulators, offering a novel therapeutic strategy.
1 article
Researchers designed new proteins called GEMs that target GPCRs, like the dopamine D1 receptor, as diverse allosteric modulators, offering a novel therapeutic strategy.